Illness	Number of cases
Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00)	297
Malignant neoplasm of bronchus and lung (C34.9)	82
Malignant neoplasm of breast (C50.9)	80
Malignant neoplasm of ovary (C56)	73
Malignant neoplasm of bronchus and lung (C34.8)	64
Malignant neoplasm of bronchus and lung (C34.0)	60
Malignant neoplasm of pancreas - Malignant neoplasm of head of pancreas (C25.0)	49
Malignant neoplasm of breast (C50.8)	45
Malignant neoplasm of prostate (C61)	44
Malignant neoplasm of bronchus and lung (C34.1)	43

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.0)	1.627
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	1.001
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	372
(9-984.7)	311
Uniform basic assessment in terminal care (1-774)	307
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.22)	197
(9-984.8)	155
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	151
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.32)	102
(9-984.b)	102

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500 , 3752

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Brustkrebs

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ05

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
162	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
94	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
91	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Project-related cooperation with colleges and universities
Editors of scientific journals/textbooks
Student training (clinical traineeship / internship year)
Doctoral supervision
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Participation in multi-centre Phase I/II studies
Lectureships / teaching posts at colleges and universities

Training

No.	Training in other healing professions	Comment
HB10	Midwife (m/f)	In Kooperation mit Kath. Stiftungshochschule
HB03	Physical therapist / physiotherapist (m/f)	In Kooperation mit Döpfner Schulen München
HB19	Nursing professionals
HB17	Auxiliary nurse (m/f)
HB15	Anaesthesia technical assistant (m/f)
HB07	Surgical technical assistant (m/f)
HB20	Nursing professional B. Sc.	In Kooperation mit Münchner Hochschulen